A detailed history of National Bank Of Canada transactions in Legend Biotech Corp stock. As of the latest transaction made, National Bank Of Canada holds 210,100 shares of LEGN stock, worth $6.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
210,100
Holding current value
$6.07 Million
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$31.43 - $39.7 $6.6 Million - $8.34 Million
210,100 New
210,100 $7.13 Million
Q2 2022

Jul 28, 2022

BUY
$33.54 - $55.0 $845,208 - $1.39 Million
25,200 New
25,200 $1.39 Million
Q1 2022

May 05, 2022

SELL
$31.02 - $48.18 $2.21 Million - $3.44 Million
-71,300 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$41.14 - $56.98 $2.93 Million - $4.06 Million
71,300 New
71,300 $3.32 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $4.84B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.